In 2004 396,481 persons in Belgium were reimbursed at least one package of diabetes medication of whom 104,780 were prescribed insulin therapy; in 2010 this was respectively 489,559 and 136,753 [2]. The gene discussed is INS; the disease is diabetes mellitus.